自1979年12月至1983年1月,我们对101例肺性脑病并高粘度综合征患者,应用大剂量抗血小板功能药物配合其他药物(下称抗肺脑合剂)与非抗血小板功能药物(下称传统药物)进行了对比治疗。结果表明,应用抗肺脑合剂的有效率、治愈率都优于传统药物,取得令人满意的疗效。本文旨在结合我们的临床实践,对抗肺脑合剂的临床应用价值进行初步探讨,同时对肺性脑病并高粘度综合征的发病原因及临床表现兼作概述。 From December 1979 to January 1983, we treated 101 patients with pulmonary encephalopathy and high-viscosity syndrome with high-dose anti-platelet drugs in combination with other drugs (anti-lung-brain mixture) and non-antiplatelet drugs Hereinafter referred to as traditional medicine) were compared treatment. The results show that the application of anti-pulmonary brain mixture efficiency, the cure rate is superior to traditional drugs, and achieved satisfactory results. This article aims to combine our clinical practice, the clinical application of anti-pulmonary brain mixture for preliminary study, at the same time on the pathogenesis of pulmonary encephalopathy and high viscosity syndrome and clinical manifestations as both.